EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review

Selvarani Subbarayan iD, Imogen Smith-Dodd, Gabriel Nicolson, Jennifer K Burton iD, Janet T Scott, Seshadri S Vasan iD, Susan D Shenkin iD, Roy L Soiza iD, WATCH Consortium

Age and Ageing · 04.04.2026 · 55 (4)

DOI: 10.1093/ageing/afag077 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Age and Ageing, online erschienen am 09.04.2026. Verfasst von Selvarani Subbarayan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ageing Clinical and Experimental Research Group, The Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, Univer…. Hauptthemen laut MEDLINE: Patient Selection, Nursing Homes, Clinical Trials as Topic, Homes for the Aged. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Legal and General PLC as part of their corporate social responsibility (CSR) programme, Moderna under its Vaccine Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Excluding Care Home (CH) residents from clinical trials of medicines and vaccines has led to an evidence gap. Findings from younger adults may not be generalisable to CH residents with frailty and dementia. Therefore, it is essential to evaluate pharmacological treatments directly in CH residents to assess their safety and efficacy.

Methods

As part of the Widening Access to Trials in Care Homes project, we conducted a scoping review using Joanna Briggs Institute methodology to identify barriers and facilitators to recruiting CH residents into clinical trials of medicinal products. We searched EMBASE, MEDLINE, PsycINFO, CINAHL, and the Cochrane Library (1990 to January 2025). Quantitative data on screen failures and dropouts, and qualitative data on trial teams’ real-world experiences and stakeholder perspectives were extracted, synthesised into themes and presented as descriptive summaries.

Results

From 14,301 records, eight articles were included (2002 to 2021) from the USA (N = 4), UK (N = 3) and France (N = 1). Six were RCTs, and two were a qualitative sub-study and a questionnaire survey. Screen failure rates ranged from 18% to 96%. Identified themes of barriers and facilitators were study design, selection criteria, recruitment methods, data collection methods, participant retention, CH resident and family-related factors, CH facility and staff-related factors, healthcare professional involvement, logistical and operational factors, consent-related factors, ethical and regulatory considerations, insurance and trial costs, and generalisability of trial results.

Conclusions

Our review specifically identified key barriers and facilitators to recruiting CH residents into pharmacological trials. These findings can guide trial planning and support evidence-based care for this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient SelectionNursing HomesClinical Trials as TopicHomes for the AgedVaccinesHumansNursing Home ResidentsAged

Stichwörter der Autor:innen

barriers and facilitatorscare home residentscare homesnursing homesolder peoplerandomised controlled trialsvaccine trials

Substanzen

Vaccines

Autor:innen und Institutionen

  • Ageing Clinical and Experimental Research Group, The Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.
  • Academic Geriatric Medicine, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Research, Development and Innovation, NHS Highland, Inverness, UK.
  • School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • Centre for Virus Research, University of Glasgow, Glasgow, UK.

ORCID-Profile: Selvarani Subbarayan, Jennifer K Burton, Seshadri S Vasan, Susan D Shenkin, Roy L Soiza

Förderung

  • Legal and General PLC as part of their corporate social responsibility (CSR) programme
  • Moderna under its Vaccine Innovation Fund

Zitieren

APA

Subbarayan, S., Smith-Dodd, I., Nicolson, G., Burton, J. K., Scott, J. T., Vasan, S. S., Shenkin, S. D., Soiza, R. L., & WATCH Consortium (2026). Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review. Age and Ageing, 55(4). https://doi.org/10.1093/ageing/afag077

Vancouver

Subbarayan S, Smith-Dodd I, Nicolson G, Burton JK, Scott JT, Vasan SS, et al. Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review. Age and Ageing. 2026;55(4). doi:10.1093/ageing/afag077

BibTeX
@article{Subbarayan2026,
  author = {Subbarayan, Selvarani and Smith-Dodd, Imogen and Nicolson, Gabriel and Burton, Jennifer K and Scott, Janet T and Vasan, Seshadri S and Shenkin, Susan D and Soiza, Roy L and WATCH Consortium, WATCH Consortium},
  title = {Barriers and facilitators to recruiting older adult care home residents into clinical trials of medicines and vaccines: a scoping review},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {4},
  doi = {10.1093/ageing/afag077}
}
Kostenlos starten →